Clinical Trials Logo

Peritonitis clinical trials

View clinical trials related to Peritonitis.

Filter by:

NCT ID: NCT02926846 Completed - Kidney Failure Clinical Trials

IV Antibiotics With Lavage for Severe PD Peritonitis

Start date: March 2014
Phase: Phase 4
Study type: Interventional

This is a randomized controlled trial to evaluate whether a switch to intravenous antibiotics with adjunctive lavage can improve the outcome of severe peritoneal dialysis related peritonitis.

NCT ID: NCT02895919 Withdrawn - Ascites Clinical Trials

Bedside Inoculation of Ascitic Fluid in Diagnostic Paracentesis

Start date: August 22, 2016
Phase:
Study type: Observational

This study seeks to determine non inferiority of direct inoculation of ascitic fluid in lab as compared to current culture media standard, bedside inoculation with blood culture bottles.

NCT ID: NCT02882932 Completed - Peritonitis Clinical Trials

Comparative Evaluation of Intra-operative Peritoneal Lavage With Super Oxidized Solution and Normal Saline in Peritonitis Cases

Start date: December 2014
Phase: Phase 2
Study type: Interventional

Super Oxidized Solution (SOS) was used in peritonitis and results were compared by using normal saline solution in two groups. Abdominal fluid was taken to check for bacterial load after giving lavage with SOS solution and in other group normal saline. SOS is a high level disinfectant, non-flammable and no special training is required to handle it.

NCT ID: NCT02872038 Completed - Clinical trials for Peritoneal Dialysis Associated Peritonitis

Comparing Cefepime Versus Cefazolin Plus Ceftazidime for CAPD-associated Peritonitis

Start date: August 2015
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the efficacy of empirical antibiotics of CAPD-associated peritonitis with intraperitoneal, continuous dosing of cefepime monotherapy versus combination of cefazolin and ceftazidime. Patients were randomized to be administered either intraperitoneal cefepime 1 g loading then 250 mg all exchanges (treatment group) or cefazolin and ceftazidime (control group) in the same dose.

NCT ID: NCT02846948 Completed - Sepsis Clinical Trials

The Impact of Focused Transthoracic Echocardiography in Urgent Abdominal Surgery for Septic Patients

ECHOCARD
Start date: January 2016
Phase: N/A
Study type: Interventional

The aim of the study is to identify the diagnostic value of the focused assessed echocardiography in septic patients undergoing urgent abdominal surgery due to peritonitis. The investigators expect that the incidence of hemodynamic instability will be reduced and the survival of the patients will be improved.

NCT ID: NCT02821364 Withdrawn - Peritonitis Clinical Trials

Philadelphia Immediate Transport in Penetrating Trauma Trial

PIPT
Start date: February 1, 2020
Phase: N/A
Study type: Interventional

PIPT Trial (Philadelphia Immediate Transport in Penetrating Trauma Trial) A prospective randomized clinical trial comparing pre-hospital procedures to immediate transportation in patients with penetrating injury and shock.

NCT ID: NCT02805049 Completed - Septic Shock Clinical Trials

Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis

Start date: January 28, 2017
Phase: Phase 4
Study type: Interventional

The main objective of this study is to describe the pharmacokinetics of the prescribed echinocandins for septic shock with secondary peritonitis for which intra-abdominal fungal infection is suspected or proven.

NCT ID: NCT02798939 Terminated - Liver Cirrhosis Clinical Trials

Evaluation of Lactoferrin, Procalcitonin and Aution® Urine Dipsticks for the Diagnosis of Spontaneous Bacterial Peritonitis in Cirrhotic Patients

Start date: March 1, 2010
Phase:
Study type: Observational

Bacterial infections are a major cause of mortality in cirrhotic patients in the context of gastrointestinal bleeding or spontaneous bacterial peritonitis (SBP). Rapid diagnosis of SBP is therefore an important research goal because the gold standard neutrophil count in ascitic fluid cannot be performed 24 hours a day in all healthcare structures. The use of urine dipsticks in ascites cannot be recommended at the present time due to their insufficient sensitivity with an unacceptable risk of false-negatives in the context of a fatal disease for which effective antibiotic therapy is available. Ascitic fluid lactoferrin assay has recently been demonstrated to be a very good diagnostic test for SBP. The investigators plan to conduct a prospective study on lactoferrin as well as procalcitonin (PCT) to determine the best laboratory test(s) for the rapid, automated diagnosis of SBP. These tests will be compared with the Aution® urine dipstick, which has been shown to present better diagnostic sensitivity than the Multistix® dipstick . This single-centre study (Amiens University Hospital) will be performed in the context of routine clinical practice on ascitic fluid that is usually incinerated.

NCT ID: NCT02787057 Completed - Clinical trials for Peritoneal Dialysis Associated Peritonitis

Vancomycin Plus Moxifloxacin Versus Vancomycin Plus Ceftazidime for the Treatment of Peritoneal Dialysis (PD)-Related Peritonitis

PD
Start date: November 2012
Phase: N/A
Study type: Interventional

Intra-peritoneal administration of antibiotics covering both gram-positive and gram-negative organisms was recommended as first-line regimen for the management of peritoneal dialysis related peritonitis. Oral administration of quinolones can also achieve effective serum concentrations, and is more convenient and economical. We conducted a pilot randomized controlled study to compare the effects on peritonitis cure and relapsing rates between oral moxifloxacin plus IP vancomycin and conventional IP vancomycin plus ceftazidime.

NCT ID: NCT02759497 Recruiting - Clinical trials for Spontaneous Bacterial Peritonitis

Evaluation of Serum Amyloid A in Early Diagnosis of Spontaneous Bacterial Peritonitis

Start date: March 2016
Phase: N/A
Study type: Observational

One of the most common and serious complications in decompensated cirrhotic patients (DCPs) is bacterial infection.The most common infections in DCPs are cases of spontaneous bacterial peritonitis (SBP), which account for 40% 70% of cases, followed by urinary tract infections, pneumonia and cellulitis. Serum amyloid A (SAA) and C-reactive protein (CRP) are acute-phase proteins predominantly produced and secreted by hepatocytes. Other cells including lymphocytes, monocytes, and macrophages can also produce these proteins. The induction of SAA and CRP synthesis is triggered by a number of cytokines, chiefly IL-6, which is released from a variety of cell types, but mainly from macrophages and monocytes at inflammatory sites